Skip to content

Castle Biosciences CSTL Segment Reporting Other Item Amount

Segment Reporting Other Item Amount at other companies

CONMED logo
CONMEDCNMD
$6.23M+6.4%
Century Communities logo
Century CommunitiesCCS
$22.22M+279%
EyePoint, Inc.
 logo
EyePoint, Inc. EYPT
$4.06M+16.7%
Essential Utilities logo
Essential UtilitiesWTRG
-$75K+74.4%
Radiant Logistics logo
Radiant LogisticsRLGT
-$271K-113%
Equitable Holdings logo
Equitable HoldingsEQH
$371M-5.1%

Segments

By segment

See full
Reportable Segment$12.25M-66.9%

Other financials

Income statement

See full
Revenue$83.7M-4.9%
Gross profit$63.1M-11.8%
Operating income-$18.4M+34.1%
Net income-$14.5M+43.8%
EPS (diluted)-$0.49+45.6%

Balance sheet

See full
Cash & equivalents$63.8M-28.9%
Total debt$36.7M+42.1%
Total equity$461.4M+4.8%
Total assets$547.8M+9.2%

Cash flow

See full
Operating cash flow-$22.1M-267%
CapEx$12.5M+163%
Free cash flow-$34.6M-221%

Valuation

See full
Market cap$694.86M+29.9%
Enterprise value$667.82M+41.8%
P/S+0.5×

Profitability

See full
Gross margin77.9%-4.1pp
Operating margin-9.8%-30.8pp
Net margin-3.8%-10.2pp
FCF margin1.3%-10.7pp

Returns & leverage

See full
Return on equity-2.8%-10.6pp
Debt / equity0.1×0.0×
Current ratio6.7×-2.6×